Spotlighting the most promising biotechnology companies in Israel.

Although it is a smaller country, Israel’s biotechnology sector is flourishing. According to Ernst & Young, BioIsrael has recently experienced a boost of venture capital placing it among the ranks of larger biotech companies. With more capital, IsraelBio has been able to increase the number of products within Phase III development. IsraelBio also boasts a large number of students and graduates in life sciences, showing promise for future growth and development.


Hotbed News
BioPharm Executive: Here's How The Drug Industry Will Finally Hang Itself Thursday, May 28, 2015
Teva (TEVA) Buys Stake in Mylan (MYL), As Takeover Attempt Turns Nasty Thursday, May 28, 2015
BioSpace (DHX) Temperature Poll: Will PfizerKline Become the Next Pharma Player? Thursday, May 28, 2015
Mylan (MYL) Chairman Tells Investors He Would Consider Buying Rival Teva (TEVA) Tuesday, May 19, 2015
Kamada Ltd. (KMDA) Reports Updated Data From European Phase II/III Clinical Study Of Inhaled Alpha-1 Antitrypsin To Treat AAT Deficiency Wednesday, May 20, 2015
Parsing Biotech's B-Word: Why Growing Bubble Fear May Be Your Opportunity Thursday, April 30, 2015
Israeli Startup Ninox Nabs $10 Million Series B Friday, May 01, 2015
BioSpace (DHX) Temperature Poll: Will Mylan (MYL) Buy Teva (TEVA), As Predator Becomes Prey? Wednesday, May 20, 2015
Teva (TEVA) Presents Further Data From Phase IIb With TEV-48125 In Chronic Migraine At The International Headache Society Congress (IHC): Efficacy And Safety Results At All Doses And Endpoints Present Robust Case For Progression To Phase III Thursday, May 14, 2015
MelCap Electronic Pill to Help Treat Obesity, Eating Disorders Friday, April 24, 2015